The reduced expression of MAP1LC3A in WS may therefore result in insufficient degradation of unhealthy cells in the brain of individuals with WS, or that unnecessary or dysfunctional components in those cells will not be removed properly. The gene discussed is MAP1LC3A; the disease is Werner syndrome.